HomeNDC LookupIngredientsSalicylic Acid › 10107-0250-08
WartStick Salicylic Acid .4 g/g Stick, 1 tube — NDC 10107-0250-08 package photo

WartStick Salicylic Acid .4 g/g Stick, 1 tube

by Balassa Laboratories Inc. · 1 TUBE in 1 CARTON (10107-250-08) / 5.1 g in 1 TUBE (10107-250-01)
NDC 10107-0250-08
🏷️ FDA NDC (as labeled) 10107-250-08 billing pads the product segment with a zero
This package
Contains1 tube Pack sizes5 compare ↓
OTC Discontinued Non-controlled ⚠ Discontinued by firm
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

🆔 Identity & classification

FDA NDC (as labeled) 10107-250-08
Product NDC 10107-250
11-digit billing NDC 10107025008
RxCUI 251407, 2043252
UNII O414PZ4LPZ
UPC 0083467248000, 0083467252250, 0083467246242, 0083467251253
Application # M028
SPL Set ID 6ffae85f-7ada-4350-9cd5-0396ea4d9314
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 1983-06-01
Route TOPICAL
Dosage form STICK
Substance SALICYLIC ACID
Why two NDCs? The FDA registers this code as 10107-250-08 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 10107-0250-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerBalassa Laboratories Inc.
FDA applicationM028 (OTC MONOGRAPH DRUG)
Labeler code10107
First marketedJun 1983
Product typeHuman Otc Drug
Portfolio7 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • It's designed to treat acne. Salicylic acid helps by loosening and removing dead skin cells that clog pores — the buildup that leads to breakouts. The multi-step system on this lab...
  • What is this salicylic acid product actually supposed to do for my skin?
  • Some mild tingling, stinging, and peeling is actually expected — that's the salicylic acid doing its job by clearing away dead skin cells. But if the burning or peeling feels exces...
  • My skin feels like it's burning and peeling. Is that normal?
📖 Read our full Salicylic Acid Topical guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color yellow
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D5340Y2I9G
    Castor oil is a natural plant-based oil used in medicines as a lubricant, laxative agent, and solvent. It helps medicine ingredients dissolve or flow smoothly and can aid bowel movement in formulations designed for that purpose.
  • UNII HM4YQM8WRC
    Chlorobutanol is a colorless crystalline chemical used as a preservative in medicines. It prevents bacterial and fungal growth to maintain product safety and shelf life.
  • UNII I9O0E3H2ZE
    Paraffin is a waxy, petroleum-derived substance used as a coating, lubricant, and hardening agent in tablets and capsules. It helps protect the medicine from moisture and gives pills a smooth finish.
  • UNII 88S87KL877
    Rosin is a sticky resin extracted from pine trees. It's used in medicines as a binder and adhesive to help hold tablet ingredients together and improve how the medicine sticks to surfaces.
  • UNII 2ZA36H0S2V
    Beeswax is a natural wax produced by honeybees. In medicines, it works as a coating agent and thickener to control how fast the drug dissolves and improve the product's texture and appearance.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCastor oil, chlorobutanol, paraffin, rosin, yellow wax

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 5.1 g 5.1 g 5.1 g 2 tubes
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
CornStick .4 g/g 10107-0240-02 Balassa 1 tube FDA listed
WartStick .4 g/gthis 10107-0250-08 Balassa 1 tube Discontinued
WartStick Plantar .4 g/g 10107-0251-02 Balassa 1 tube FDA listed
Propolis Wart Remover Stick 40 g/100g 83004-0029-01 Rida 1 tube FDA listed
SupreH Solid Wart Remover Stick 40 g/1001 83818-0027-01 Shenzhen 2 sticks FDA listed
Salicylic Acid 40% / Corn Remover .4 g/g 51511-0599-12 ASO 16800 patches FDA listed
Scholls Wellness Company LLC Duragel Callus Remover .4 g/g 73469-0644-01 Scholls 4 pouches FDA listed
Scholls Wellness Company LLC One Step Corn Removers .4 g/g 73469-0753-01 Scholls 6 pouches FDA listed
One Step Wart Removers .4 g/g 73469-6321-04 Scholls 14 pouches FDA listed
Scholls Wellness Company LLC DURAGEL CORN REMOVER .4 g/g 73469-0627-01 Scholls 6 pouches FDA listed
Clear Away Wart Removers .4 g/g 73469-6421-02 Scholls 12 pouches FDA listed
Plantar Wart Removers .4 g/g 73469-6331-02 Scholls 12 pouches FDA listed
Compound W Corn Remover .4 g/g 63029-0599-08 Medtech 8 patches FDA listed
Scholls Wellness Company LLC DS EXTRA THICK CALLUS REMOVER .4 g/g 73469-0463-01 Scholls 4 pouches FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1983
On the market since
Jun 1983
📍
2026
Currently FDA-listed
43 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
10107-0250-02 1 TUBE in 1 CARTON (10107-250-02) / 5.1 g in 1 TUBE (10107-250-01) 2017-05-12 Active
10107-0250-03 2 TUBE in 1 CARTON (10107-250-03) / 5.1 g in 1 TUBE (10107-250-01) 2017-03-13 Active
10107-0250-08 You're viewing this 1 TUBE in 1 CARTON (10107-250-08) / 5.1 g in 1 TUBE (10107-250-01) 2018-08-23 Discontinued by firm
10107-0250-20 1 TUBE in 1 KIT (10107-250-20) / 5.1 g in 1 TUBE (10107-250-01) 2024-10-01 Active
10107-0250-21 1 TUBE in 1 KIT (10107-250-21) / 5.1 g in 1 TUBE (10107-250-01) 2024-10-01 Active

Pack size FAQ

What quantity is in NDC 10107-0250-08?
NDC 10107-0250-08 contains 1 tube — 1 tube in 1 carton / 5.1 g in 1 tube.
What is the difference between NDC 10107-0250-08 and NDC 10107-0250-02?
Both are WartStick Salicylic Acid .4 g/g Stick — the drug itself is identical. NDC 10107-0250-08 is the 1 tube package, while NDC 10107-0250-02 is the 1 tube package.
What NDC number is used to bill for this package of WartStick Salicylic Acid .4 g/g Stick?
Bill NDC 10107-0250-08 — the 11-digit billing format is 10107025008. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 10107-250-08, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 10107-0250-08, written without dashes as 10107025008. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 10107-0250-08, the first segment (10107) is the labeler code FDA assigned to Balassa Laboratories Inc.; the middle segment (0250) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (08) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 1 tube (10107-0250-02), 1 tube (10107-0250-20), 1 tube (10107-0250-21). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Balassa Laboratories Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 51 words

Uses For the removal of common warts. The common wart is easily recognized by the rough "cauliflower-like" appearance of the surface. For the removal of plantar warts. The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

⏱️ Dosage and Administration 52 words

Directions Wash affected area May soak in warm water for 5 minutes Dry area thoroughly Keeping the product off the surrounding skin, apply a thin layer of the product to each wart Cover affected area with clean bandage Repeat procedure daily as needed (until wart is removed) for up to 12 weeks

⚠️ Warnings 75 words

Warnings For external use only. Do not use if you are a diabetic on irritated, infected, or reddened skin if you have poor blood circulation on warts with hair growing from them on moles or birthmarks on face, genitals, or mucous membranes Stop use and ask a doctor if irritation occurs or discomfort persists Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 11 words

Other Information Replace cap when finished and store at room temperature

🧪 Active Ingredient 6 words

Active Ingredient Salicylic acid 40% (w/w)

🧪 Inactive Ingredients 9 words

Inactive Ingredients Castor oil, chlorobutanol, paraffin, rosin, yellow wax

🎯 Purpose 3 words

Purpose Wart remover

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.